Ocular copper deposition associated with benign monoclonal gammopathy and hypercupremia

Cornea

Volumn 15, Issue 1, 1996, Pages 94-98

  Probst, Louis E ^a   Hoffman, Eck ^a   George Cherian, M ^a   Yang, J ^a   Feagan, Brian ^a   Adams, Paul ^a   Nichols, Bruce ^a  

^a LONDON HEALTH SCIENCES CENTRE   (Canada)

Author keywords

Benign monoclonal gammopathy; Copper; Cornea; Hypercupremia

Indexed keywords

COPPER; IMMUNOGLOBULIN G;

AGED; ARTICLE; CASE REPORT; CLINICAL FEATURE; COPPER BLOOD LEVEL; CORNEA OPACITY; DISEASE ASSOCIATION; HUMAN; MALE; MONOCLONAL IMMUNOGLOBULINEMIA; PRIORITY JOURNAL; PROTEIN BINDING; VISUAL IMPAIRMENT;

EID: 0030050441     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003226-199601000-00017     Document Type: Article

References (26)

1. Goodman SI, Rodgerron DO, Katuman J. Hypercupremia in a patient with multiple myeloma. J Lab Clin Med 1967;70: 57-62.
2. Ellis PP. Ocular deposition of copper in hypercupremia. Am J Ophthalmol 1969;68:423-7.
3. Lewis RA, Falls HF, Troyer DO. Ocular manifestations of hypercupremia associated with multiple myeloma. Arch Ophthalmol 1975;93:1050-3.
4. Lewis AR, Hultquist DE, Baker BL, Falls HF, et al. Hypercupremia associated with a monoclonal immunoglobulin. J Lab Clin Med 1976;88:376-88.
5. Alpern M, Bastian B, Pugh EN Jr, Gras W. Altered ocular pigments, photostable and labile: two causes of deuteranomalous trichromacy. Mod Probt Ophthal 1976;17:273-91.
6. Martin NF, Kincaid MC, Sark WJ, Petty BG, et al. Ocular copper deposition associated with pulmonary carcinoma, IgG monoclonal gammopathy and hypercupremia: a clinicopathologic correlation. Ophthalmology 1983;90:111-5.
7. Sarkar B. Biological specificity of the transport process of copper and nickel. Chemica Scipta 1983;21:101-8.
8. Sarkar B, Wigfield Y. Evidence for albumin-Cu(II)-amino acid ternary complex. Can J Biochem 1968;46:601-7.
9. Evans GW. Copper homeostasis in the mammalian system. Physiol Rev 1973;53:535-70.
10. Cook CS, Grubb B. Experimental hypercupremia does not result in increases in copper in the lens, iris, or ocular fluids. Curr Eye Res 1986;5:171-3.
11. Brown DH, Buchanan WW, El-Ghobarey AF, et al. Serum copper and its relationship to clinical symptoms in rheumatoid arthritis. Ann Rheum Dis 1979;38:174-6.
12. Linquist RR. Studies on the pathogenesis of hepatolenticular degeneration III. The effect of copper on the liver lysosomes. Am J Pathol 1968;53:903-22.
13. Tso MOM, Fine BS, Thorpe HE. Kayser-Fleischer ring and associated cataract in Wilson's disease. Am J Ophthalmol 1975;79:479-88.
14. Danks DM, Stevens BJ, Campbell PE, et al. Menkes' kinky hair syndrome. Lancet 1972;1:1100-3.
15. Vulpe C, Levinson B, Whitney S, Packman S, Gitschier J. Isolation of a candidate gene for Menkes disease and evidence that it encodes a copper transporting ATPase. Nature Genetics 1993;3:7-13.
16. Bull PC, Thomas GR, Rommens JM, Forbes JR, Cox DW. The Wilson disease gene is a punitive copper transporting P-type ATPase similar to the Menkes gene. Human Genetics 1993;5:327-37.
17. Fleming CR, Dickson ER, Wahner HW, Hollenhorst RW, et al. Pigmented corneal rings in non-Wilsonian liver disease. Ann Intern Med 1977;86:285-8.
18. Rao NA, Tso MOM, Rosenthal AR. Chalcosis of the human eye: A clinicopathological study. Arch Ophthalmol 1976;94: 1379-84.
19. Delaney WV Jr. Presumed ocular chalcosis: A reversible maculopathy. Ann Ophthalmol 1975;7:378-80.
20. Bouchel MJ, Gerhard JP. Impregnation cuprique du segment anterieur apres traitement local ausulfate de cuivre, confirmation par dosage. Bull Soc Ophtalmol Fr 1964;64:936-9.
21. Duke-Elder S, ed. System of ophthalmology, vol 8, pt 2: Diseases of the outer eye, cornea and sclera. St. Louis: CV Mosby, 1965:976-92.
22. Brewer GJ, Gretchen MH, Dick RD, Nostrant TT. Treatment of Wilson's disease with zinc: III. Prevention of reaccumulation of hepatic copper. J Lab Clin Med 1987;109:526- 31.
23. Crawford J, Eye MK, Cohen HJ. Evaluation of monoclonal gammopathies in the "well" elderly. Am J Med 1987;82:39- 45.
24. Kyle RA. "Benign" monoclonal gammopathies: a misnomer. JAMA 1984;251:1849-54.
25. Rodrigues MM, Krachmer JH, Miller SD, Newsome DA. Posterior corneal crystalline deposits in benign monoclonal gammopathy: A clinicopathologic case report. Arch Ophthalmol 1979;97:124-8.
26. Barr CC, Gelender H, Font RL. Corneal crystalline deposits associated with dysproteinemia. Report of two cases and review of the literature. Arch Ophthalmol 1980;98:884-9.